with T 4 . 1 The importance of TH for central nervous system (CNS) development becomes also evident in the Allan-Herndon-Dudley Even before birth, TH is crucial for embryonic CNS development. However, because the foetal thyroid gland only starts folliculogenesis around embryonic day 15 (E15) in mice 9 and does not produce hormone until shortly before birth in mice (corresponding to the beginning of the third trimester in humans), whereas nuclear TH receptors (TRs) are already present in the developing brain from embryonic day E13.5, the required TH during this critical period is provided by the mothers. 10, 11 Consequently, maternal hypothyroxinaemia (e.g. as a result of iodine deficiency of the mother) can severely affect offspring brain development. 12 Despite these clear links between TH supply and brain development, little is known about the neuroanatomical targets of TH in the developing brain. T 3 action is largely mediated by TRα1 and TRβ (encoded by Thra and Thrb, respectively), with TRα1 accounting for 70%-80% of the TR in the adult brain, 13 whereas TRβ controls selective functions such as the feedback loop of the hypothalamic-pituitarythyroid axis. 14 The major isoform for almost all neurones, however, is TRα1, being expressed in mice in postmitotic neurons from E13.5 onwards throughout neuronal maturation into adulthood. 15 TRs are transcription factors that bind to thyroid hormone response elements in the promotor region of target genes independently of ligand availability 14, 16 and activate or suppress gene expression depending on the presence or absence of THs. 14 The importance of TRα1 signalling for neuronal development is underlined by findings in mice heterozygous for the mutant TRα1R384C (TRα1 + m). In this particular model, the affinity of the mutant TRα1R384C to T 3 is reduced 10-fold, leading to a hypothyroidlike phenotype at physiological T 3 concentrations for TRα1 targets.
However, when T 3 concentrations are increased 10-fold (e.g. by TH treatment), the receptor can be reactivated in vivo. 17 TRα1 + m mice show anxiety and memory deficiencies, as well as motoric deficits, associated with a reduced number of neurones expressing the Ca 2+ -binding protein parvalbumin (PV) in the hippocampus 18 and motor cortex, respectively. 19 In these mice, another TH sensitive population of PV neurones was identified in the anterior hypothalamic area (AHA), which was strongly reduced in TRα1 + m mice. 20 The ablation of these neurones in wild-type (WT) animals leads to an increase in blood pressure and heart rate, 20 suggesting that they play an important role in the regulation of the cardiovascular system. However, the development of these AHA PV neurones has never been studied and their dependency on TH is not well characterised.
In the present study, we show that AHA PV neurones are born at E12 and reach their destination in the AHA between P8 and P13.
By contrast to cortical PV neurones, however, PV neurones in the AHA do not require TH postnatally but depend on TRα1 mediated T 3 signalling between E12 and birth, a period when the hormone is provided by the mother. 
| MATERIAL S AND ME THODS

| Animal husbandry
| Bromodeoxyuridine (BrdU) birth dating
Wt C57BL/6J mice were mated and females were separated after a positive plug (defined as E0 .5) Triton-X 100 for 1 hour. Subsequently sections were incubated in 5% NGS, biotin (avidin/biotin blocking kit; Vector Laboratories), 0.3%
| Immunohistochemistry
Triton-X 100 and rabbit anti-PV primary antibody (see Supporting information, Table S1A) at 4°C overnight. Next, sections were treated with a biotinylated secondary antibody (see Supporting information, Table S1B) in 0.3% Triton-X 100 followed by ABC-Solution (ABC-kit; Vector Laboratories) for 1 hour each and stained in DABsolution (0.5 mg mL -1 ). Sections were mounted and dried overnight at room temperature (RT), dehydrated and cleared in xylene, and cover slipped using pertex (Medite GmbH, Burgdorf, Germany). Cell counts were obtained as described previously. 20 Sections incubated without first or secondary antibody were used as controls and did not show any stainings.
| Immunofluorescence
Immunofluorescence staining was performed on 4% PFA fixed, free-floating 20-μm cryostat coronal sections of WT C57BL/6J
animals. All solutions were prepared with 1× PBS. Sections from BrdU treated mice were blocked for 1 hour with 5% NGS and 0.3% Triton-X 100, followed by incubation in rabbit anti-PV primary antibody (Table S1A) in blocking solution at RT overnight.
Next, sections were incubated in Alexa Fluor 488 labelled secondary antibody (Table S1B ) for 1 hour followed by antigen retrieval borate buffer at RT). Subsequently, sections were incubated in rat anti-BrdU primary antibody (Table S1A) in blocking solution at RT overnight. Finally, sections were incubated for 1 hour in Alexa
Fluor 594 secondary antibody (Table S1B) . WT samples were treated with 10 mmol L -1 Na-Citrate at 80°C for 10 minutes for antigen retrieval and blocked with 5% normal donkey serum (SigmaAldrich, St Louis, MO, USA) and 0.3% Triton-X 100. Next, sections
were incubated in goat anti-PV primary antibody in combination with rabbit anti-vesicular glutamate transporter 2 (VGLUT2) (Table   S1A ), as well as rabbit anti-PV primary antibody in combination with mouse anti-GAD67 (Table S1A ), in blocking solution at 4°C
overnight. Subsequently, sections were incubated for 1 hour using the respective secondary antibodies (Table S1B ). All slices were mounted on object slides using ProLong Diamond Antifade reporter mice was processed as described previously 25, 26 with a rabbit anti-PV primary antibody (Table S1A ) and an Alexa Fluor 568 labelled secondary antibody (Table S1B ).
| Statistical analysis
Statistical analysis was performed using Prism, version 5 or 6
(GraphPad Software Inc., San Diego, CA, USA). P and t values were obtained using an unpaired 2-tailed Student's t-test for simple comparison with WT controls or 2-way ANOVAs for comparisons involving genotype and treatment with subsequent Holm-Sidak post-hoc tests for multiple comparisons. P < .05 (*), P < .01 (**) and P < .001 (***) were considered statistically significant. All data are reported as the mean ± SEM.
| RE SULTS
| Development and basic characterisation of AHA PV neurones
Because the development of AHA PV neurones has not been studied to date, we initially aimed to determine their appearance in the AHA postnatally. PV immunoreactivity in the AHA was first detected at postnatal day 8 (P8) and rose gradually until a population of PV neurones equivalent to the number in adult mice was detected at P13 ( Figure 1A,B) . Next, we aimed to define the respective "birth-dates" of these neurones (ie, their transition from proliferation to a postmitotic state in relation to cortical PV neurones). Accordingly, proliferating neurones were labelled with BrdU at different time points after conception during embryonic development, and the amount of BrdU-labelled PV positive neurones in the AHA was determined postnatally at the age of 6 weeks ( Figure 1C , overview; Figure 1D , high magnification of the AHA at E11.5). We found that the percentage of BrdU labelled PV neurones in the AHA showed maximum labelling at E11.5 and E12.5 and already declined at E13.5 ( Figure 1C ; see also Supporting information, Figure S1A ). This is in contrast to cortical PV neurones that continuously increased from E9.5 onwards, with a maximum on day E13.5 (see Supporting information, Figure S1B ), as expected from previous studies, 27, 28 
| Impaired postnatal TH signalling has no influence on PV neurones in the AHA
To identify the period within the developmental program in which PV neurones depend on TH signalling, we analysed PV immunoreactivity in the cerebral motor cortex and the AHA from two different animal models for impaired postnatal TH signalling: Pax8 KO mice, which are an established model for congenital hypothyroidism 4 and do not have detectable level of TH after birth as a result of the lack of a thyroid gland, and Mct8/Oatp1c1 DKO mice, which exhibit a pronounced TH deficiency postnatally in the CNS because, with the tightening of the BBB starting at E16, TH entering the brain is no longer possible as a result of the lack of these two transporters. 6 In both animals, we observed a reduced PV immunoreactivity in the motor cortex compared to control littermates in agreement with previous studies, 6 whereas the AHA population of 
| The development of PV neurones in the AHA is directly influenced by maternal TH
Based on our findings that PV neurones in the AHA are born around E12 but do not appear to require the hormone postnatally, we speculated that their critical window for TH signalling might occur prenatally. To test this hypothesis, we took advantage of the TRα1 + m strain, which has the R384C mutation in TRα1 that lowers affinity to the ligand TH by a factor of 10, thus rendering it essentially unresponsive at physiological TH concentrations.
However, the mutant TRα1 can be reactivated in vivo at any time via an elevation of TH levels. First, we specifically reactivated the embryonic mutant TRα1 throughout the entire pregnancy using
TRβ KO females 23 with high endogenous levels of TH as dams.
17, 19
When we then analysed the male TRα1 + m and control offspring of these hyperthyroid mothers, we observed a significant interaction between treatment and TRα1 mutation (2-way ANOVA effect of TRα1 genotype P < .0001, effect of maternal TH P = .495, interaction P = .048) ( Figure 3A 
| D ISCUSS I ON
In the present study, we investigated the developmental characteristics of a recently discovered population of PV neurones in the AHA. 20 Because these neurones control cardiovascular functions, and can cause hypertension if not developed properly, our data reveal an important neuroanatomical target of maternal hypothyroxinemia and provide further mechanistic evidence for the link between maternal TH concentrations during pregnancy and offspring blood pressure.
Given that this correlation is also observed in humans, 31 the present study has potentially great clinical relevance for the ongoing controversial discussions concerning the treatment of thyroid disorders during pregnancy.
| Characteristics of PV neurones in the AHA
PV is a Ca 2+ -binding protein commonly used as a marker for specific neurones in the hippocampus, the cerebral cortex, the spinal cord and the cerebellum. 32 In the cerebral cortex, PV neurones represent one of three separate subpopulations (PV + , SST + and 5HT3a + ) of inhibitory GABAergic interneurones, [33] [34] [35] which arise depending on the subtype from the MGE, CGE or preoptic area. 28, 30, 36 A common feature of neurones from the MGE and the preoptic area is their developmental expression of Nkx2-1, 37,38 whereas CGE neurones express 5HT3a. 34 Consequently, our data exclude the possibility that PV neurones in the AHA originate from the MGE or the preoptic area as a result of the lack of double staining between PV and Nkx2-1 triggered expression of RFP. Moreover, the developmental programme of hypothalamic PV neurones appears to be independent of NKX2-1, which is in line with the observation that the development of the hypothalamus in Nkx2-1 null mice is only slightly impaired. 39 In addition to a distinct origin, the time of birth is a crucial characteristic determining the developmental pattern and subsequently the fate of neurones. The BrdU birth-dating indicated that the majority of PV precursor cells leave mitosis between E11.5 and E12.5, followed by migration and differentiation until the first detection of mature PV neurones in the AHA on P8. This is in line with older anatomical studies, defining the time of birth of most AHA neurones between E10 and E16 with a peak at E11-E14. 40 Moreover, a neighbouring population of hypothalamic PV neurones located in the parvafoxnucleus of the ventrolateral hypothalamus 41 is born at the same time, 42 raising the possibility that these two populations might share TRα1 pv+ Migration/Differentiation a common origin. However, in contrast to AHA and cortical PV neurones, these neurones appeared not to be affected by TH during development, 19, 20 suggesting that the underlying mechanisms of PV neurone development in the AHA are likely different from those of cortical or parvafox PV neurones.
| Role of maternal TH during pregnancy
Although several populations of PV neurones throughout the brain have been shown to be a target of TH, 18, 19 the majority of studies has focused on the interplay of TH and cortical PV neurones. 43 These neurones show TRα1 expression from E13.5 onwards, 15 and the lack of TH in rats beginning on E14 leads to reduced PV expression and axonal development in cortical PV neurones. 44 However, when we analysed mouse models of impaired TH signalling from birth onwards, we observed that the loss of postnatal TH signalling alone appears sufficient to strongly reduce the numbers of cortical PV neurones. Most remarkably, PV neurones in the AHA were not affected, suggesting that they might be more advanced in their developmental programme at birth and already independent of postnatal TH. Because it was previously shown that PV neurones in the AHA require TH for development, 20 we concluded that the critical window for TH sensitivity had to be prenatal. Moreover, our data from the Pax8 −/− mice, which exhibit no reduction in AHA PV neurones, conclusively show that hormones produced by the foetal thyroid gland, even prenatally, are not required for the development of these neurones.
Therefore, we aimed to rescue hypothalamic PV neurones in TRα1 + m embryos by a timed reactivation of the mutant TRα1 with high maternal TH levels throughout the entire pregnancy. This was first tested using TRβ KO mothers because they have endogenously elevated levels of TH throughout life. 17, 23 Unexpectedly, this approach had only a minor rescuing effect on the AHA population of PV neurones in TRα1 + m offspring; however, because the neuronal number seemed also decreased in WT offspring, we concluded that high maternal TH could also have a negative effect on the system at some point during pregnancy, potentially by TRβ, which would also be activated by the high levels of TH. However, when we repeated the experiment on a TRβ KO background, 23 we observed that the effect of maternal TH on TRα1 + m mice was prevented, suggesting that TRβ might be required but appears to play only a minor role.
Because TRα1 expression starts only at E13.5 in postmitotic cells, 15 we speculated that treatment of WT mothers with T 3 from E12.5
until birth would have a much stronger beneficial effect because it only targets the critical TRα1 dependent period and avoids high TH levels during earlier periods. Indeed, this treatment fully rescued the neuronal impairment in TRα1 + m offspring, demonstrating that liganded TRα1 is crucially important in the second half of pregnancy starting around E12, coinciding with the developmental switch of the neurones from proliferation to differentiation and migration and before the onset of foetal TH production at the end of pregnancy.
11
With regard to a possible negative effect of TH before E12.5
and the potential role of TRβ, the situation is somewhat complex.
Because TH is first detected in the foetal brain around E13, 45 , showing, in rat, that TRβ1 expression is associated with proliferative zones, whereas TRα1 is expressed in postmitotic neurones that had ceased proliferation and entered a phase of differentiation. Consequently, it is likely that high TH before E12.5 might also be detrimental for PV neurone development; the role of TRβ in this context, however, remains enigmatic as a result of the lack of reliable data on its developmental expression at the cellular level in the brain.
Taken together, these findings clearly show that TH action in the developing nervous system needs to be tightly orchestrated to guarantee proper differentiation and migration. The precise timing appears to be different for individual PV cell populations; however, for PV neurones in the AHA, the levels of maternal TH during the second half of murine pregnancy are the decisive factor, where the thyroid gland of the foetus is not yet fully functional. 11 For the human situation, this corresponds to the second trimester because mice are born prematurely in comparison and, similarly, the foetal production of TH is only initiated during this time. This suggests that the development of the central control of cardiovascular functions might also be dependent on maternal TH in humans, although there are certain species specific differences between thalamic neuronal migration mechanisms. 48 Indeed, a recent observation on a Danish cohort revealed that children from subclinical hypothyroid women display a higher systolic blood pressure at the age of 20 years compared to the control group. 31 Most remarkably, hypertension was also found in children from subclinically hyperthyroid mothers, which indicates that the dual role of TH during neuronal development might also exists in humans. This observation could be of particular clinical relevance for children of mothers displaying resistance to TH as a result of a mutation in TRβ because, in this condition, the foetus is exposed to very high levels of TH throughout pregnancy with often poor outcomes. 49 Taken together, we have identified that PV neurones in the AHA are an exclusive target of maternal TH, which, for the first time, links maternal endocrinology to a defined neuroanatomical substrate in the offspring. These findings not only underline the well-known role of TH for brain development, but also provide the central control of cardiovascular functions as an important end-point to take into consideration when discussing the relevance of routine maternal thyroid screening in pregnancy. 50 Moreover, the findings might be of great relevance for animal models testing the role of endocrine disrupting compounds during pregnancy. 51 
